Adaptive Biotechnologies Corporation
NASDAQ:ADPT
4.78 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 43.19 | 41.873 | 45.784 | 37.919 | 48.926 | 37.647 | 55.198 | 47.83 | 43.66 | 38.62 | 37.93 | 39.467 | 38.505 | 38.442 | 30.185 | 26.299 | 20.988 | 20.91 | 24.209 | 26.058 | 22.138 | 12.666 | 17.192 | 17.188 | 11.568 | 9.715 |
| Cost of Revenue
| 22.102 | 18.051 | 25.008 | 19.346 | 17.91 | 18.681 | 16.589 | 14.907 | 13.221 | 13.192 | 14.356 | 14.189 | 10.765 | 9.991 | 6.222 | 6.053 | 4.912 | 5.343 | 5.951 | 5.601 | 5.734 | 4.988 | 5.275 | 5.36 | 5.044 | 3.989 |
| Gross Profit
| 21.088 | 23.822 | 20.776 | 18.573 | 31.016 | 18.966 | 38.609 | 32.923 | 30.439 | 25.428 | 23.574 | 25.278 | 27.74 | 28.451 | 23.963 | 20.246 | 16.076 | 15.567 | 18.258 | 20.457 | 16.404 | 7.678 | 11.917 | 11.828 | 6.524 | 5.726 |
| Gross Profit Ratio
| 0.488 | 0.569 | 0.454 | 0.49 | 0.634 | 0.504 | 0.699 | 0.688 | 0.697 | 0.658 | 0.622 | 0.64 | 0.72 | 0.74 | 0.794 | 0.77 | 0.766 | 0.744 | 0.754 | 0.785 | 0.741 | 0.606 | 0.693 | 0.688 | 0.564 | 0.589 |
| Reseach & Development Expenses
| 22.992 | 30.245 | 23.783 | 28.533 | 32.237 | 32.601 | 31.222 | 35.658 | 37.037 | 37.839 | 34.699 | 36.072 | 37.8 | 33.772 | 35.831 | 30.314 | 25.992 | 23.935 | 21.189 | 20.506 | 16.527 | 12.483 | 11.067 | 9.783 | 9.452 | 8.855 |
| General & Administrative Expenses
| 17.895 | 19.597 | 20.726 | 20.075 | 22.302 | 20.831 | 22.428 | 20.755 | 21.2 | 24.144 | 23.346 | 20.154 | 16.066 | 14.936 | 13.398 | 12.079 | 12.238 | 11.821 | 8.189 | 8.477 | 6.662 | 7.004 | 6.495 | 4.739 | 4.632 | 4.543 |
| Selling & Marketing Expenses
| 20.314 | 22.319 | 21.906 | 20.493 | 23.872 | 22.308 | 23.716 | 21.513 | 24.281 | 26.093 | 26.696 | 24.949 | 23.216 | 20.604 | 18.545 | 14.474 | 14.332 | 14.007 | 12.64 | 9.099 | 8.897 | 7.817 | 8.071 | 6.039 | 5.329 | 5.047 |
| SG&A
| 37.529 | 41.916 | 42.632 | 40.568 | 46.174 | 43.139 | 46.144 | 42.268 | 45.481 | 50.237 | 50.042 | 45.103 | 39.282 | 35.54 | 31.943 | 26.553 | 26.57 | 25.828 | 20.829 | 17.576 | 15.559 | 14.821 | 14.566 | 10.778 | 9.961 | 9.59 |
| Other Expenses
| 7.629 | 0.423 | 25.858 | 0.428 | 0.423 | 0.419 | 0.429 | 0.428 | 0.423 | 0.419 | 0.429 | 0.428 | 0.423 | 0.419 | 0.428 | 0.428 | 0.423 | 0.424 | 0.428 | 0.428 | 0.423 | 0.419 | 0.428 | 0.428 | 0.424 | 0.419 |
| Operating Expenses
| 60.521 | 72.584 | 66.415 | 69.529 | 78.834 | 76.159 | 77.795 | 78.354 | 82.941 | 88.495 | 85.17 | 81.603 | 77.505 | 69.731 | 68.202 | 57.295 | 52.985 | 50.187 | 42.446 | 38.51 | 32.509 | 27.723 | 26.061 | 20.989 | 19.837 | 18.864 |
| Operating Income
| -39.433 | -48.762 | -45.639 | -50.956 | -47.818 | -57.193 | -39.186 | -45.431 | -52.502 | -63.067 | -61.596 | -56.325 | -49.765 | -41.28 | -44.239 | -37.049 | -36.909 | -34.62 | -24.188 | -18.053 | -16.105 | -20.045 | -14.144 | -9.161 | -13.313 | -13.138 |
| Operating Income Ratio
| -0.913 | -1.165 | -0.997 | -1.344 | -0.977 | -1.519 | -0.71 | -0.95 | -1.203 | -1.633 | -1.624 | -1.427 | -1.292 | -1.074 | -1.466 | -1.409 | -1.759 | -1.656 | -0.999 | -0.693 | -0.727 | -1.583 | -0.823 | -0.533 | -1.151 | -1.352 |
| Total Other Income Expenses Net
| -6.815 | 1.229 | -23.828 | 0.656 | 0.008 | -0.507 | -0.983 | 0.112 | 0.418 | 0.271 | -0.019 | 0.327 | 0.464 | 0.638 | 0.785 | 1.018 | 1.893 | 2.894 | 3.577 | 4.103 | 0.446 | 1.659 | 0.873 | 0.869 | 0.82 | 0.747 |
| Income Before Tax
| -46.248 | -47.533 | -69.467 | -50.3 | -47.811 | -57.7 | -40.169 | -45.319 | -52.084 | -62.796 | -61.357 | -55.998 | -49.301 | -40.642 | -43.454 | -36.031 | -35.016 | -31.726 | -20.611 | -13.95 | -15.659 | -18.386 | -13.271 | -8.292 | -12.493 | -12.391 |
| Income Before Tax Ratio
| -1.071 | -1.135 | -1.517 | -1.327 | -0.977 | -1.533 | -0.728 | -0.948 | -1.193 | -1.626 | -1.618 | -1.419 | -1.28 | -1.057 | -1.44 | -1.37 | -1.668 | -1.517 | -0.851 | -0.535 | -0.707 | -1.452 | -0.772 | -0.482 | -1.08 | -1.275 |
| Income Tax Expense
| -0.026 | 4.196 | -0.026 | -5.763 | 3.612 | 4.037 | -15.647 | -0.15 | -0.456 | -0.271 | -0.182 | -2.198 | -1.757 | -1.732 | 1.116 | 0.688 | -1.481 | -0.323 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -46.222 | -47.507 | -69.441 | -50.3 | -47.81 | -61.737 | -24.522 | -45.169 | -51.628 | -62.525 | -61.433 | -55.998 | -49.301 | -40.642 | -44.57 | -36.719 | -33.535 | -31.403 | -20.611 | -13.95 | -15.659 | -18.386 | -13.271 | -8.292 | -12.493 | -12.391 |
| Net Income Ratio
| -1.07 | -1.135 | -1.517 | -1.327 | -0.977 | -1.64 | -0.444 | -0.944 | -1.183 | -1.619 | -1.62 | -1.419 | -1.28 | -1.057 | -1.477 | -1.396 | -1.598 | -1.502 | -0.851 | -0.535 | -0.707 | -1.452 | -0.772 | -0.482 | -1.08 | -1.275 |
| EPS
| -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.43 | -0.17 | -0.32 | -0.37 | -0.44 | -0.44 | -0.4 | -0.35 | -0.29 | -0.33 | -0.27 | -0.26 | -0.25 | -0.17 | -0.11 | -1.18 | -0.15 | -0.13 | -0.078 | -0.12 | -0.12 |
| EPS Diluted
| -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.43 | -0.17 | -0.32 | -0.36 | -0.44 | -0.43 | -0.4 | -0.35 | -0.29 | -0.33 | -0.27 | -0.26 | -0.25 | -0.17 | -0.11 | -1.18 | -0.15 | -0.13 | -0.078 | -0.12 | -0.12 |
| EBITDA
| -34.43 | -39.326 | -40.247 | -50.956 | -38.553 | -48.746 | -36.155 | -39.283 | -47.307 | -58.011 | -61.167 | -52.797 | -46.86 | -38.609 | -43.811 | -34.905 | -34.911 | -32.642 | -23.76 | -15.99 | -14.235 | -18.262 | -12.551 | -7.696 | -11.822 | -11.687 |
| EBITDA Ratio
| -0.797 | -0.939 | -0.879 | -1.344 | -0.788 | -1.295 | -0.655 | -0.821 | -1.084 | -1.502 | -1.613 | -1.338 | -1.217 | -1.004 | -1.451 | -1.327 | -1.663 | -1.561 | -0.981 | -0.614 | -0.643 | -1.442 | -0.73 | -0.448 | -1.022 | -1.203 |